Evgen Pharma (GB:TCF) has released an update.
First Equity Limited, an investment firm based in London, has altered its stakes in Theracryf PLC, crossing a threshold on June 12, 2024, which resulted in a change in their total voting rights from 5.896849% to 4.797040% of the company. The notification, which includes details of direct voting rights and the controlling entities involved, indicates a significant transaction that could interest investors tracking ownership changes in UK-based companies.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
